Influence of Chitosan type on the properties of extruded pellets with low amount of microcrystalline cellulose

AAPS PharmSciTech

Volumn 8, Issue 3, 2007, Pages

  Charoenthai, Nattawut ^a   Kleinebudde, Peter ^b   Puttipipatkhachorn, Satit ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Chitosan; Drug release; Extrusion spheronization; Pellets; Sodium alginate

Indexed keywords

ALGINIC ACID; CALCIUM PHOSPHATE DIBASIC; CHITOSAN; MICROCRYSTALLINE CELLULOSE; PARACETAMOL; CELLULOSE; GLUCURONIC ACID; HEXURONIC ACID;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG GRANULATION; DRUG RELEASE; MOLECULAR SIZE; MOLECULAR WEIGHT; NANOPHARMACEUTICS; PELLET EXTRUSION; PH; PHARMACEUTICAL ENGINEERING; PHYSICAL CHEMISTRY; SPHERONIZATION; CHEMISTRY; PARTICLE SIZE; SOLUBILITY;

ALGINATES; CELLULOSE; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; GLUCURONIC ACID; HEXURONIC ACIDS; MOLECULAR WEIGHT; PARTICLE SIZE; SOLUBILITY;

EID: 34548287037     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt0803064     Document Type: Article

References (38)

1. Bechgaard H, Nielsen GH. Controlled release multiple units and single-unit doses. Drug Dev Ind Pharm. 1978;4:53-67.
2. Reynolds AD. A new technique for the production of spherical particles. Mfg Chem Aerosol News. 1970;41:40-43.
3. Vervaet C, Baert L, Remon JP. Extrusion-spheronisation: a literature review. Int J Pharm. 1995;116:131-146.
4. O'Conner RE, Schwartz JB. Spheronization II: drug release from drug-diluent mixture. Drug Dev Ind Pharm. 1985;11:1837-1857.
5. Schröder M, Kleinebudde P. Development of disintegrating pellets obtained from extrusion/spheronization. J Pharm Sci. 1995; 1:415-418.
6. Zimm KR, Schwartz JB, O'Connor RE. Drug release from a multiparticulate pellet system. Pharm Dev Technol. 1996;1:37-42.
7. Tapia C, Buckton G, Newton JM. Factors influencing the mechanism of release from sustained release matrix pellets, produced by extrusion/ spheronisation. Int J Phann. 1993;92:211-218.
8. Goskonda SR, Upadrashta SM. Avicel RC-591/chitosan beads by extrusion-spheronization technology. Drug Dev Ind Pharm. 1993;19:915-927.
9. Santos H, Veiga F, Pina M, Podczeck F, Sousa J. Physical properties of chitosan pellets produced by extrusion-spheronisation: influence of formulation variables. Int J Pharm. 2002;246:153-169.
10. Chatchawalsaisin J, Podczeck F, Newton JM. The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation. Int J Pharm. 2004;275:41-60.
11. Sriamornsak P, Nunthanid J, Luangtana-anan M, Puttipipatkhachorn S. Alginate-based pellets prepared by extrusion/spheronization: a preliminary study on the effect of additive in granulating liquid. Eur J Pharm Biopharm. 2007;67:227-235.
12. Neau SH, Chow MY, Durrani MJ. Fabrication and characterization of extruded and spheronized beads containing Carbopol 974P. Int J Pharm. 1996;131:47-55.
13. Bommareddy GS, Paker-Leggs S, Saaripella KK, Neau SH. Extruded and spheronized beads containing Carbopol® 974P to deliver nonelectrolytes and salts of weakly basic drugs. Int J Pharm. 2006;321:62-71.
14. Steckel H, Mindermann-Nogly F. Production of chitosan pellets by extrusion/spheronization. Eur J Pharm Biopharm. 2004;157:107-114.
15. Agrawal AM, Howard MA, Neau SH. Extruded and spheronized beads containing no microcrystalline cellulose: influence of formulation and process variables. Pharm Dev Technol. 2004;9:197-217.
16. Charoenthai N, Kleinebudde P, Puttipipatkhachom S. Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization. J Pharm Sci. 2007;96: 2469-2484.
17. Tho I, Sande SA, Kleinebudde P. Disintegrating pellets from a water-insoluble pectin derivative produced by extrusion/spheronisation. Eur J Pharm Biopharm. 2003;56:371-380.
18. Bornhöft M, Thommes M, Kleinebudde P. Preliminary assessment of carrageenan as excipient for extrusion/spheronisation. Eur J Pharm Biopharm. 2005;59:127-131.
19. Thommes M, Kleinebudde P. Use Of κ-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/ spheronisation I: influence of type and fraction of filler. Eur J Pharm Biopharm. 2006;63:59-67.
20. Thommes M, Kleinebudde P. Use of κ-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/ spheronisation II: influence of drug and filler type. Eur J Pharm Biopharm. 2006;63:68-75.
21. Felt O, Buri P, Gurny R. Chitosan: a unique polysaccharide for drug delivery. Drug Dev Ind Pharm. 1998;24:979-993.
22. Ilium L. Chitosan and its use as a pharmaceutical excipient. Pharm Res. 1998;15:1326-1331.
23. Paul W, Sharma CP. Chitosan, a drug carrier for the 21st century: a review. STP Pharma Sci. 2000;10:5-22.
24. Nunthanid J, Puttipipatkhachorn S, Yamamoto K, Peck GE. Physical properties and molecular behavior of chitosan films. Drug Dev Ind Pharm. 2001;27:143-157.
25. Voegele D, Brockmeier D, Von Hattingberg HM, Lippold BC. Mean dissolution time - a parameter for testing release condition comparability. Acta Pharm Technol. 1983;29:167-174.
26. Costa FO, Sousa JJS, Pais AACC, Formosinho SJ. Comparison of dissolution profiles of ibuprofen pellets. J Control Release. 2003;89:199-212.
27. Korsmeyer RW, Gurny R, Doelker EM, Buri P, Peppas NA. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25-35.
28. Ritger PL, Peppas NA. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release. 1987;5:37-42.
29. Takahashi T, Takayama K, Machida Y, Nagai T. Characteristics of polyion complexes of chitosan with sodium alginate and sodium polyacrylate. Int J Pharm. 1990;61:35-41.
30. Baert L, Fanara D, Debaets P, Remon JP. Instrumentation of a gravity feed extruder and the influence of the composition of binary and ternary mixtures on the extrusion force. J Pharm Pharmacol. 1991;43:745-749.
31. Fielden KE, Newton JM, Rowe RC. The influence of moisture content on spheronization of extrudate processed by a ram extruder. Int J Pharm. 1993;97:79-92.
32. Kleinebudde P, Lindner H. Experiments with an instrumented twin-screw extruder using a single-step granulation extrusion process. Int J Pharm. 1993;94:49-58.
33. Lustig-Gustafsson C, Kaur Johal H, Podczeck F, Newton JM. The influence of water content and drug solubility on the formulation of pellets by extrusion and spheronization. Eur J Pharm Sci. 1999;8:147-152.
34. Wan LSC, Heng PWS, Liew CV. Spheronization conditions on spheroid shape and size. Int J Pharm. 1993;96:59-65.
35. Blair HS, Guthrie J, Law T, Turkington P. Chitosan and modified chitosan membranes I: preparation and characterization. J Appl Polym Sci. 1987;33;641-645.
36. Hodsdon AC, Mitchell JR, Davies MC, Melia CD. Structure and behavior in hydrophilic matrix sustained release dosage forms 3: the influence of pH on the sustained release performance and internal gel structure of sodium alginate matrices. J Control Release. 1995;33:143-152.
37. Fernández-Hervás M, Holgado M, Fini A, Fell JT. In vitro evaluation of alginate beads of diclofenac salt. Int J Pharm. 1998; 163:13-34.
38. Murata Y, Miyamoto, E, Kawashima S. Additive effect of chondroitin sulfate and chitosan on drug release from chitosan-induced alginate gel beads. J Control Release. 1946;38:101-108.